---  
layout: startup_page  
title: "Maze Therapeutics"  
id: "mazetx.com"  
permalink: "/mazetherapeuticsmazetx.com12032024/"  
website: "https://www.mazetx.com"  
funding_round: "Series D"  
funding_amount: "$115M"  
investors: "Frazier Life Sciences, Deep Track Capital, Janus Henderson Investors, Logos Capital, Third Rock Ventures, ARCH Venture Partners, Matrix Capital Management, GV, General Catalyst, Andreessen Horowitz, Foresite Capital, Woodline Partners LP, Casdin Capital, Piper Heartland Healthcare Capital, Moore Strategic Ventures"  
about: "Maze Therapeutics is a clinical-stage biopharmaceutical company developing novel, small molecule precision medicines for renal, cardiovascular, and metabolic diseases. They utilize their Compass platform to identify genetic variants linked to disease pathways, enabling the creation of targeted therapies. Their pipeline is led by two programs, MZE829 and MZE782, addressing significant unmet needs in kidney disease."  
markets: "Biotechnology, Pharmaceuticals, Precision Medicine, Genetics, Therapeutics"  
hq: "South San Francisco, California, United States"  
founded_year: "2017"  
linkedin: "https://www.linkedin.com/company/mazetx/"  
twitter: "https://twitter.com/MazeInBiotech"  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/maze-therapeutics/"  
pitchbook: "https://pitchbook.com/profiles/company/264926-44"  

date_display: "03-Dec-2024"  
date: "2024-12-03"

# SEO Optimization  
meta_title: "Maze Therapeutics - Series D Funding ($115M)"  
meta_description: "Maze Therapeutics, Maze Therapeutics is a clinical-stage biopharmaceutical company developing novel, small molecule precision medicines for renal, cardiovascular, and me..."  
meta_keywords: "Maze Therapeutics, Biotechnology, Pharmaceuticals, Precision Medicine, Genetics, Therapeutics, Series D funding"  
canonical_url: "https://startup.projectstartups.com/mazetherapeuticsmazetx.com12032024/"  
---